Enzyme discovery may hold key to cancer treatments

A major discovery could open the door to "one-fits-all" cancer drugs that can tackle many different forms of the disease.









Researchers have started to unmask an enzyme that plays a major role in the development of nearly all human cancers.



The work may lead to drugs that de-activate the enzyme, and prevent the uncontrolled cell division that leads to cancer.



Experts have been trying for more than a decade to devise anti-cancer therapies that target the enzyme, telomerase. But they have been thwarted by lack of knowledge about the molecule's construction.



Researchers have now deciphered the enzyme's active region and worked out the most important part of its structure.



The new findings, published in the online edition of the journal Nature, reveal atomic-level details of telomerase showing how it works to replicate the ends of chromosomes - a process critical both to tumour development and ageing.



The results are expected to boost development of telomerase inhibitors.



Study leader Dr Emmanuel Skordalakes, from The Wistar Institute in Philadelphia, US, said: "Telomerase is an ideal target for chemotherapy because it is active in almost all human tumours, but inactive in most normal cells. That means a drug that deactivates telomerase would likely work against all cancers, with few side effects."



Telomerase helps prevent the chromosomes - bundles of DNA which contain the genes - suffering damage and the loss of genetic information during cell division.



The enzyme adds protective "caps" known as "telomeres" to the ends of chromosomes which act like the plastic tips on shoe laces that prevent fraying.



When telomerase is dormant, the telomeres shorten each time a cell divides, eventually leading to genetic instability and cell death. This is a key element of the ageing process.



The enzyme is active in cells that multiple frequently, such as immature cells in embryos, but switched off almost completely in normal adult cells.



However cancer cells often regain the ability to activate telomerase, allowing them to replicate indefinitely, and the enzyme has been implicated in 90 per cent of human tumours.



For this reason deactivating telomerase could halt tumour growth.



Unravelling the mysteries of telomerase may also pave the way to therapies that combat ageing and age-related diseases.



Re-activating dormant telomerase in a controlled, safe way, could theoretically produce younger, healthier and longer living tissue.



Understanding telomerase's structure is the first step towards achieving these goals.



But the molecule is complex, made up of multiple protein domains - three dimensional structures that can function independently of each other - as well as a stretch of the genetic "template" RNA.

Life and Style
ebookNow available in paperback
ebooks
ebookA delicious collection of 50 meaty main courses
Latest stories from i100
Have you tried new the Independent Digital Edition apps?

ES Rentals

    Independent Dating
    and  

    By clicking 'Search' you
    are agreeing to our
    Terms of Use.

    iJobs Job Widget
    iJobs General

    Recruitment Genius: Cleaner

    £15000 - £16500 per annum: Recruitment Genius: If you've got first class custo...

    Recruitment Genius: Mobile Applications Developer / Architect - iOS and Android

    Negotiable: Recruitment Genius: This is a great opportunity to join a medium s...

    Recruitment Genius: Telesales Account Executive - £40K OTE

    £11830 - £40000 per annum: Recruitment Genius: Working in a friendly, sales ta...

    Recruitment Genius: Web Designer

    £15000 - £27000 per annum: Recruitment Genius: One of the UK's leading web des...

    Day In a Page

    Greece debt crisis: What happened to democracy when it’s a case of 'Vote Yes or else'?

    'The economic collapse has happened. What is at risk now is democracy...'

    If it doesn’t work in Europe, how is it supposed to work in India or the Middle East, asks Robert Fisk
    The science of swearing: What lies behind the use of four-letter words?

    The science of swearing

    What lies behind the use of four-letter words?
    The Real Stories of Migrant Britain: Clive fled from Zimbabwe - now it won't have him back

    The Real Stories of Migrant Britain

    Clive fled from Zimbabwe - now it won’t have him back
    Donna Karan is stepping down after 30 years - so who will fill the DKNY creator's boots?

    Who will fill Donna Karan's boots?

    The designer is stepping down as Chief Designer of DKNY after 30 years. Alexander Fury looks back at the career of 'America's Chanel'
    10 best statement lightbulbs

    10 best statement lightbulbs

    Dare to bare with some out-of-the-ordinary illumination
    Dustin Brown: Who is the tennis player who knocked Rafael Nadal out of Wimbeldon 2015?

    Dustin Brown

    Who is the German player that knocked Nadal out of Wimbeldon 2015?
    Wimbledon 2015: Nick Bollettieri - It's time for big John Isner to produce the goods to go with his thumping serve

    Nick Bollettieri's Wimbledon Files

    It's time for big John Isner to produce the goods to go with his thumping serve
    Tour de France 2015: Twins Simon and Adam Yates have a mountain to climb during Tour of duty

    Twins have a mountain to climb during Tour of duty

    Yates brothers will target the steepest sections in bid to win a stage in France
    John Palmer: 'Goldfinger' of British crime was murdered, say police

    Murder of the Brink’s-MAT mastermind

    'Goldfinger' of British crime's life ended in a blaze of bullets, say police
    Forget little green men - aliens will look like humans, says Cambridge University evolution expert

    Forget little green men

    Leading evolutionary biologist says aliens will look like humans
    The Real Stories of Migrant Britain: An Algerian scientist adjusts to life working in a kebab shop

    The Real Stories of Migrant Britain

    An Algerian scientist struggles to adjust to her new life working in a Scottish kebab shop
    Bodyworlds museum: Dr Gunther von Hagens has battled legal threats, Parkinson's disease, and the threat of bankruptcy

    Dying dream of Doctor Death

    Dr Gunther von Hagens has battled legal threats, Parkinson's disease, and the threat of bankruptcy
    UK heatwave: Temperature reaches 39.8 degrees on Central Line - the sweatiest place in London

    39.8 degrees recorded on Tube

    There's hot (London) and too damn hot (the Underground). Simon Usborne braved the Central line to discover what its passengers suffer
    Kitchens go hi-tech: From robot chefs to recipe-shopping apps, computerised cooking is coming

    Computerised cooking is coming

    From apps that automatically make shopping lists from your recipe books to smart ovens and robot chefs, Kevin Maney rounds up innovations to make your mouth water
    Jessie Cave interview: The Harry Potter star has published a feminist collection of cartoons

    Jessie Cave's feminist cartoons

    The Harry Potter star tells Alice Jones how a one-night stand changed her life